Comparable companies
- CHASPIERRE HOLDINGVerviers
- TAM PHARMASint-Jans-Molenbeek
- JDS PharmaLa Louvière
- PHARMA LEYENSLiège
- Pharma PoperingeGent
LINDA PHARMA
ActiveFrom the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of LINDA PHARMA is 2.1% (moderate). The 2025 annual accounts show equity of €43,688 and a net result of €34,521. Its solvency ranks better than 36% of 22,726 sector peers (NACE 47, financial year 2025). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
KBO- Status
- Active since 03-07-2025 Normal situation
- Legal form
- Private limited company
- Registered office
- Leopoldstadplein 16, 1040 Etterbeek
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment units
- 2.375.649.368 1040 Etterbeek, since 03-07-2025
- 2.376.914.625 1040 Etterbeek, since 03-07-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 25-12-2025
How it is doing
- Bankruptcy probabilitywithin 12 months
- 2.1%
Annual accounts 2025
- Gross margin
- €60,555
- Turnover
- ≈ €290,000
- estimated
- Profit
- €34,521
- Equity
- €43,688
- Total assets
- €258,710
- Staff
- 0.3 FTE
2025 accounts filed 27 days late
Filed on 27-08-2026at the National Bank
Why 54raises riskFounded in 2025Sector: Retail trade (NACE 47)Size: total assets €258,7102 establishment unitsShow the evidence
Checked score
Score 2025
54
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 49% of its sector peers (NACE 47, micro)
Financial strength
Average
Solvency
42
equity 16.9% of total assets
Liquidity
38
short-term debt 47.3% · cash 9.0%
Profitability
85
return on assets 13.3%
Bankruptcy probability, 12 months
2.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
08-2026: 2.2%highest value
09-2026: 1.8%▼ -0.4 percentage points vs 08-2026lowest value
10-2026: 2.1%▲ +0.3 percentage points vs 09-2026
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.34, below the usual 1.5; short-term debt: 47.3% and cash: 9% of total assets), and 83.1% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 33% on solvency, 35% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
raises risk
raises risk · 2025 accounts filed 27 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filingDeviation from the deadline
2025
27 days late
← before the deadline
after the deadline →
Searched, nothing found (1)
Key points
- Positive: Among the best 18% on net resultsector median €5,089 · 22,707 companies €34,521 View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 27-08-2026
Acts in the Belgian Official Gazette
- Incorporationact of 07-07-2025
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about LINDA PHARMA
- What is the company number of LINDA PHARMA?
- 1025.098.275. In Belgium the VAT number is the company number with BE in front: BE 1025.098.275.
- Where is LINDA PHARMA based?
- The registered office is at Leopoldstadplein 16, 1040 Etterbeek.Company details
- What does LINDA PHARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of LINDA PHARMA?
- Private limited company (BV).
- When was LINDA PHARMA founded?
- On 03-07-2025.
- Is LINDA PHARMA still active?
- Yes, LINDA PHARMA is an active enterprise in the KBO register.
- How many employees does LINDA PHARMA have?
- On average 0.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of LINDA PHARMA?
- ≈ €290,000 in financial year 2025. Estimated from the gross margin of €60,555: probably between €150,000 and €400,000, based on 44 comparable companies, NACE 477.
- Is LINDA PHARMA profitable?
- In financial year 2025, LINDA PHARMA made a profit of €34,521.
- Where can I find the annual accounts of LINDA PHARMA?
- LINDA PHARMA filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank
Companies related to LINDA PHARMA
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Is the workforce growing, and do people stay?Employer check
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.